Physician profile
Steven Lichtenstein
NPI 1518942002
$27,039.61
in general payments reported to CMS, 2019-2025
36 companies · $1,827 in 2025
The $1,827 reported for 2025 was more than what 77% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,150 · 2020: $656 · 2021: $1,962 · 2022: $2,980 · 2023: $5,847 · 2024: $6,617 · 2025: $1,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,021 · Food and Beverage: $5,367 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,875 · Education: $28.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,020.75 |
| Food and Beverage | $5,367.37 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,875.00 |
| Education | $28.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $6,558.96 | 2019-2025 | Gattex, Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $5,100.15 | 2019-2025 | Trulance, Xifaxan, Plenvu |
| Olympus Medical Systems Corporation | $4,865.75 | 2024 | |
| Olympus Corporation | $3,570.00 | 2021-2023 | |
| Abbvie INC. | $2,579.47 | 2019-2025 | |
| Janssen Biotech, INC. | $995.48 | 2019-2025 | Stelara, Tremfya, Simponi |
| Braintree Laboratories, INC. | $469.24 | 2019-2025 | Suflave, Sutab |
| Celgene Corporation | $369.65 | 2022-2024 | Zeposia |
| Ardelyx, INC. | $367.24 | 2023-2025 | Ibsrela |
| Cook Medical LLC | $277.82 | 2019-2025 | Hemospray |
| Qol Medical, LLC | $234.18 | 2024-2025 | Sucraid, Sucraid |
| Aimmune Therapeutics, INC. | $174.85 | 2024-2025 | Zenpep |
| Madrigal Pharmaceuticals | $165.00 | 2024-2025 | Rezdiffra, Resmetirom |
| Janssen Scientific Affairs, LLC | $143.63 | 2024 | Tremfya |
| Gilead Sciences, INC. | $132.66 | 2023-2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $125.74 | 2019 | |
| Pfizer INC. | $123.33 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $118.74 | 2019-2024 | Dificid |
| Laborie Medical Technologies Corp. | $91.88 | 2023 | |
| Exact Sciences Corporation | $63.24 | 2023-2024 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $57.32 | 2021-2022 | |
| Olympus America INC. | $57.29 | 2025 | Single Use Repositionable Clip |
| Redhill Biopharma INC. | $56.19 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $48.94 | 2019-2020 | |
| Celltrion USA INC. | $47.42 | 2024 | Zymfentra, Vegzelma |
| Phathom Pharmaceuticals, INC. | $43.69 | 2024-2025 | Voquezna |
| Cumberland Pharmaceuticals, INC. | $39.01 | 2024 | Kristalose |
| Evoke Pharma, INC. | $29.67 | 2023-2024 | Gimoti |
| Siemens Medical Solutions USA, INC. | $22.83 | 2024 | Acuson Sequoia Diagnostic Ultrasound System |
| Fresenius Kabi USA, LLC | $19.05 | 2024 | Idacio |
| Novo Nordisk INC | $19.03 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.06 | 2023 | Dupixent |
| Ferring Pharmaceuticals INC. | $14.64 | 2019 | |
| Capsovision, INC. | $14.24 | 2025 | Capsocam Plus |
| Boston Scientific Corporation | $13.80 | 2024 | Dreamwire |
| Allergan, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Lichtenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.